Materials synthesized by organisms, such as bones and wood, combine the ability to self-repair with remarkable mechanical properties. This multifunctionality arises from the presence of living cells within the material and hierarchical assembly of different components across nanometer to micron scales. While creating engineered analogues of these natural materials is of growing interest, our ability to hierarchically order materials using living cells largely relies on engineered 1D protein filaments. Here, we lay the foundation for bottom-up assembly of engineered living material composites in 2D along the cell body using a synthetic biology approach. We engineer the paracrystalline surface-layer (S-layer) of Caulobacter crescentus to display SpyTag peptides that form irreversible isopeptide bonds to SpyCatcher-modified proteins, nanocrystals, and biopolymers on the extracellular surface. Using flow cytometry and confocal microscopy, we show that attachment of these materials to the cell surface is uniform, specific, and covalent, and its density can be controlled on the basis of the insertion location within the S-layer protein, RsaA. Moreover, we leverage the irreversible nature of this attachment to demonstrate via SDS-PAGE that the engineered S-layer can display a high density of materials, reaching 1 attachment site per 288 nm 2 . Finally, we show that ligation of quantum dots to the cell surface does not impair cell viability, and this composite material remains intact over a period of 2 weeks. Taken together, this work provides a platform for self-organization of soft and hard nanomaterials on a cell surface with precise control over 2D density, composition, and stability of the resulting composite, and is a key step toward building hierarchically ordered engineered living materials with emergent properties.
L iving organisms hierarchically order soft and hard components to create biominerals that have multiple exceptional physical properties. 1 For example, the hierarchical structure of nacre creates its unusual combination of stiffness, toughness, and iridescence. Genetically manipulating living cells to arrange synthesized materials into engineered living materials (ELMs) 2,3 opens a variety of applications in bioelectronics, 4 biosensing, 5 smart materials, 6 and catalysis. 3−7 Many of these approaches use surface display of 1D protein filaments 8−11 or membrane proteins 12, 13 to arrange materials, while cell display methods that hierarchically order materials in 2D with controlled spatial positioning and density have yet to be fully developed. This gap limits the structural versatility and degree of control available to rationally engineer ELMs.
Surface-layer (S-layer) proteins offer an attractive platform to scaffold materials in 2D on living cells due to their dense, periodic structures, which form lattices on the outermost surface of many prokaryotes 14 and some eukaryotes. 15 These monomolecular arrays can have hexagonal (p3, p6), 16, 17 oblique (p1, p2), 18, 19 or tetragonal (p4) 20 geometries and play critical roles in cell structure, 21, 22 virulence, 23 protection, 24 adhesion, 25 and more. Recombinant S-layer proteins can replace the wild-type lattice in native hosts, or can be isolated and recrystallized in vitro, on solid supports, or as vesicles. 26 These have been used for a number of applications, 26, 27 including bioremediation 28 and therapeutics 29 on cells.
To date, only two S-layer proteins have solved atomic structures, allowing for subnanometer precise positioning of attached materials: SbsB of Geobacillus stearothermophilus PV72 18 and RsaA of Caulobacter crescentus CB15. 30 Of these two S-layer proteins, there is a well-established toolkit for the genetic modification of C. crescentus, as it has been studied extensively for its dimorphic cell cycle. 31 Additionally, C. crescentus is a Gram-negative, oligotrophic bacterium that thrives in low-nutrient conditions, and while a strict aerobe, can survive microaeration. 32 Together, this makes C. crescentus particularly suitable as an ELM chassis. RsaA forms a p6 hexameric lattice with a 22 nm unit cell (Figure 1a ,b) at an estimated density of 45 000 monomers per bacterium 33 and is amenable to peptide insertions. 34 Specific protein domains have been inserted in RsaA to bind lanthanide metal ions 35 or viruses. 29 However, engineered RsaA variants currently lack the ability to assemble a variety of materials, in an irreversible fashion, and with well-characterized densityall key features needed for ELMs.
Here we engineer RsaA as a modular docking point to ligate inorganic, polymeric, or biological materials to the cell surface of C. crescentus without disrupting cell viability. This 2D assembly system is specific, stable, and allows for control over the density of attached materials without the use of chemical cues, achieving a maximal coverage of ∼25% of all possible sites, the highest density of cell-surface displayed proteins reported to our knowledge. This work forms the foundation for a new generation of hierarchically assembled ELMs.
■ RESULTS AND DISCUSSION
Design and Construction of Caulobacter crescentus S-Layer Variants for Surface Display. To display materials on the surface of C. crescentus cells, we designed a genetic module that meets four criteria: (i) a solution-exposed peptide that drives (ii) specific, stable, and stoichiometric attachment (iii) with tunable occupancy and (iv) that does not disrupt RsaA coverage. We hypothesized that varying the location of the binding peptide within RsaA might affect its solution accessibility leading to strains that have a range of occupancy. Therefore, we selected a panel of locations arrayed across the entire RsaA monomer (Figure 2a ) to insert the peptide. Smit and colleagues previously identified two sites, at amino acid positions 723 and 944, that allowed for surface display of peptides, 34 so we started with these positions. We then selected six additional sites that are known to be susceptible to proteolytic cleavage, presumably by the previously characterized S-layer Associated Protease (sapA). 36 We hypothesized these additional sites, immediately following amino acid positions 277, 353, 467, 485, 622, and 690, might be accessible in a ΔsapA strain which we created (abbreviated as CB15NΔsapA). All subsequent engineering to the eight positions within rsaA was done in this background.
To achieve specific, stoichiometric, and irreversible conjugation to RsaA, we employed the split-protein system SpyTag-SpyCatcher, 37, 38 which forms an isopeptide bond between the SpyCatcher protein and SpyTag peptide. The RsaA S-layer can accommodate insertion of large peptide sequences, 29, 35 which suggested that the 45-mer SpyTag peptide sequence, flanked on each side by a (GSSG) 4 flexible linker for accessibility, may be integrated and displayed without disrupting S-layer assembly. This modified lattice should then allow the formation of a covalent isopeptide bond between any material displaying the SpyCatcher partner protein and the SpyTag on the cell surface.
Since expression of RsaA from a p4-based plasmid in an ΔrsaA background formed a lattice structure indistinguishable from genomically expressed RsaA (Figure 1b ), we initially constructed p4-based plasmids 39 that constitutively express RsaA-SpyTag fusions (Table S2 ) and transformed them into C. crescentus JS4038. 39 Examination of the cell surface of two of these plasmid-bearing strains by AFM confirmed that RsaA-SpyTag was expressed and showed that the RsaA-SpyTag formed a S-layer lattice with the same nanoscale ordering as wild-type RsaA (Figure 1b−d) . However, we observed Figure S1 ). For this reason, we integrated SpyTag and its linkers directly into the genomic copy of rsaA (Figure 2b ) in the CB15NΔsapA background (Table S1 ). We notate these strains based on the SpyTag insertion site, e.g., rsaA690:SpyTag denotes insertion of the SpyTag and (GSSG) 4 linkers immediately after amino acid 690. No growth defects or morphological changes are apparent in any of the engineered strains, implying that our genomic insertions do not affect cell viability, and therefore these strains were used for the rest of the study. These observations suggest the more regulated genomic expression of recombinant rsaA, a highly transcribed gene, sidesteps growth impairments. SDS-PAGE analysis of RsaA-SpyTag expression of wild-type (CB15NΔsapA) and engineered cells (rsaA:SpyTag variants) shows the expected band for wild-type RsaA at 110 kDa (Figure 2c ), in line with the observed migration of RsaA on SDS-PAGE. 40, 30 Moreover, all eight engineered proteins have comparable expression levels to wild-type RsaA and show the small increase in molecular weight associated with SpyTag and its linkers (Figure 2c ). These observations demonstrate that successful expression of SpyTag within RsaA at a range of different positions does not adversely affect RsaA expression levels.
Engineered S-Layers Specifically Display Proteins Ligated to the Cell Surface. To explore accessibility of the SpyTag peptide on the C. crescentus cell surface, we engineered and purified a fusion of SpyCatcher and mRFP1. 41−43 We incubated the wild-type and engineered rsaA690:SpyTag strains with the fluorescent SpyCatcher-mRFP1 protein or mRFP1 alone, washed away unbound protein, and visualized mRFP1 attachment to individual cells via confocal microscopy ( Figure 3 ). No significant mRFP1 fluorescence is apparent in controls that used C. crescentus expressing wild-type RsaA or mRFP1 without SpyCatcher (Figure 3a−c), indicating no significant nonspecific binding of mRFP1 to the cell surface. When SpyTag is displayed on RsaA and SpyCatcher-mRFP1 is present, bright and uniform fluorescence is observed along the morphologically normal, curved cell surface, including the stalk which is covered by the S-layer lattice 17, 30, 33 (Figure 3d ). These observations indicate engineering SpyTag into RsaA enables specific binding of a SpyCatcher fusion protein to the extracellular surface, and furthermore illustrates that engineering SpyTag into the S-layer does not substantially affect the morphology of C. crescentus.
Density of Attached Materials Is Controlled by Insertion Location. Having demonstrated specific display of proteins on the surface, we turned to the hypothesis that the solution-accessibility of the eight insertion locations within the RsaA monomer would allow us to vary the density of attached materials. To quantify this relative accessibility, we again incubated the engineered strains with SpyCatcher-mRFP1, washed away unbound protein, and measured the fluorescence intensity per cell with flow cytometry. The engineered strains show a >100-fold increase in fluorescent signal (Figure 4a ) over the wild-type control, indicating that all eight positions can ligate significant amounts of SpyCatcher fusion protein.
Among the eight engineered strains, there is a ∼5-fold variation in the levels of ligation (Table 1) , with rsaA467:SpyTag and rsaA485:SpyTag showing the highest and lowest densities of binding, respectively. These results unveil six new permissive insertion sites within RsaA and show that the amount of protein bound to the cell surface can be controlled by utilizing these different insertion points.
To test that the fusion protein is irreversibly conjugated to RsaA-SpyTag, we incubated strain rsaA467:SpyTag, which showed the highest fluorescence by flow cytometry, with SpyCatcher-mRFP1, boiled the sample for 10 min with SDS and 2-mercaptoethanol, and visualized covalent attachment by SDS-PAGE ( Figure 4b ). The band corresponding to RsaA-SpyTag ( Figure 4b ) decreases in intensity while the band corresponding to the RsaA-SpyTag-SpyCatcher-mRFP1 assembly appears in as little as 1 h and increases over 24 h. Subsequent immunoblotting of this reaction with anti-RsaA polyclonal antibodies confirms that the assembly band contains RsaA ( Figure S2 ). These observations indicate the binding is covalent.
We leveraged the formation of this covalent bond to quantify the absolute density of SpyCatcher-mRFP1 displayed on the C. crescentus cell surface. The density of the RsaA band decreases by 23 ± 5% (n = 6, refer to Methods for the details of this calculation), indicating that nearly a quarter of the rsaA467:SpyTag protein is ligated to SpyCatcher-mRFP1 after 24 h. On the basis of the estimate of 45 000 RsaA monomers per cell, 33 this translates to >11 000 copies of SpyCatcher-RFP displayed on the cell surface, an average density of 1.5 SpyCatcher-RFPs per RsaA hexamer, or 1 SpyCatcher-RFP per 288 nm 2 . Combining this information with the flow cytometry data, we calculated the percentage of the RsaA lattice that is covalently modified can be controlled over a range from 4 to 23% by varying the engineered location (Table 1 , refer to Methods for the details of this calculation). These results provide quantitative information on how to utilize positiondependent insertion of SpyTag in RsaA to tune the density of attached materials and thus substantially improve our ability to rationally engineer ELMs.
Arraying Hard and Soft Materials on the Surface of Engineered Cells. Next we sought to test whether engineered RsaA could assemble soft materials on the surface of C. crescentus. We selected elastin-like polypeptide (ELP) as our model soft material because it is well-studied, easily expressed recombinantly, and exhibits interesting temperaturedependent phase behavior. 44 We incubated a SpyCatcher-ELP-mCherry fusion protein 45 with the wild-type and rsaA690:S-pyTag strains, washed away unbound protein, and imaged individual cells by confocal microscopy. As before, we observe no significant mCherry fluorescence from incubations lacking either SpyTag or SpyCatcher (Figure 5a ,b), indicating there is no significant nonspecific binding of ELP-mCherry to the C. crescentus surface. When both SpyTag and SpyCatcher are present, we observe significant mCherry fluorescence that uniformly covers the cell surface ( Figure 5c ). This work indicates that the engineered RsaA lattice can assemble polymeric materials to the cell surface ( Figure 5 ).
To explore the diversity of structures that can be created at the cell surface using SpyCatcher-SpyTag ligation, we tested the capacity of engineered bacteria to conjugate CdSe/ZnS semiconductor quantum dots (QDs). 46, 47 SpyCatcher-functionalized QDs were generated through attachment of a hetero-bifunctional PEG linker molecule to an amphiphilic polymer encapsulating the QD surface. Subsequent incubation with SpyCatcher-Ser35Cys single cysteine mutant protein yielded QDs with surface-displayed SpyCatcher protein. We incubated PEGylated QDs and SpyCatcher-conjugated QDs (see Supporting Information) with wild-type and rsaA690:S-pyTag strains, performed a wash, and visualized individual cells via confocal microscopy. There is significant QD fluorescence along the cell body in samples containing SpyCatcher-QDs and the engineered strain, while there is no significant fluorescence with the wild-type strain ( Figure 6 ) or the PEGylated QDs. This demonstrates that hard nanomaterials can also be specifically attached to the engineered RsaA lattice.
Nanoparticle Attachment Does Not Affect Cell Viability. Finally, we explored the effect of coating the surface of the C. crescentus cells with nanoparticles on their viability, as this is key to creating hybrid living materials that remain metabolically active over time. 48 We incubated control wildtype (CB15NΔsapA) and engineered rsaA467:SpyTag cells with or without SpyCatcher-QDs for 2 weeks, sampled the cultures periodically, and enumerated the living cells (CFU/ mL). We also imaged the samples using confocal microscopy to determine whether the SpyCatcher-QDs remained stably bound to the engineered S-layer. Under all conditions, the total cell numbers decrease over the two week duration, which is expected since nutrients are not replenished (Figure 7a ). More importantly, the number of viable cells in the wild-type culture without QDs is not significantly different from the wild-type with unbound SpyCatcher-QDs, the rsaA467:SpyTag culture without QDs, or the rsaA467:SpyTag culture with SpyCatcher-QDs ( Figure 7a ). These results indicate that neither unbound SpyCatcher-QDs in the wild-type culture nor surface-bound SpyCatcher-QDs on the engineered cells affect viability, and there is no notable difference in viability between the wild-type and engineered cells. One possible interpretation of this cell viability is that the S-layer acts as an effective barrier, preventing disruption of the outer cell membrane, fulfilling one of its key evolutionary roles. 49−51 Imaging reveals that SpyCatcher-QDs remain attached to the cell surface over 2 weeks ( Figure 7B ) and nonspecific binding of SpyCatcher-QDs on the surface of wild-type cells is not observed ( Figure  S5 ), once again highlighting the specificity and stability of the SpyTag-SpyCatcher system on S-layers. We do note that QD emission decreases over the course of the experiment, which may be due to nonspecific cleavage of bonds between RsaA and the QD, turnover of the RsaA protein, or slow QD quenching in biological media. SpyCatcher-QDs incubated alone in M2G buffer show a ca. 30% decrease in emission over 14 days ( Figure S6 ), which suggests QD quenching is the likely cause of observed emission decrease in QD-RsaA conjugates. Nonetheless, these results demonstrate that engineered RsaA can be used to generate stable living materials that require cells to remain viable for extended periods of time.
Advancement of RsaA S-Layer as a Platform for Controlled Material Assembly. In summary, we show that the S-layer of C. crescentus, RsaA, is a versatile platform for cell surface attachment of proteins, biopolymers, and inorganic materials when combined with the Spy conjugation system. We demonstrate that eight sites are available for peptide insertion within RsaA and that the insertion location tunes the attachment density. Ligation to the RsaA-SpyTag lattice is highly specific and covalent, with the absolute level of density of RsaA-displayed proteins reaching ∼25% of the total RsaA, or 1 site per 288 nm 2 , which is the highest density of cellsurface displayed proteins reported to our knowledge. Moreover, we show that QD-C. crescentus composites assembled via RsaA-SpyTag form engineered living materials that persist for at least 2 weeks. In the following, we discuss possible reasons for the site-dependent variation in attachment density, specific applications for cell-display using the RsaA platform, and the broader opportunities it opens in the area of ELMs.
We observed that the relative ligation efficiency varies ∼5fold across the eight permissive sites, with rsaA467:SpyTag affording the densest array of SpyCatcher-mRFP1. This variance is not due to protein expression levels, which do not vary significantly between strains ( Figure 2c ), and is unlikely to be caused by disruption to the S-layer lattice as our findings indicate that SpyTag insertions to not alter the structure on the nanometer scale (Figure 1b−d) but may be due to solvent-accessibility within the RsaA, steric clashes between sites on nearby RsaA monomers, or a combination of these factors. The most efficient binding site, RsaA467:SpyTag, is in an unstructured loop in a gap in the hexamer (Figure 2a ), potentially giving more freedom for the SpyTag peptide to access a SpyCatcher-fusion. Since RsaA485:SpyTag and RsaA690:SpyTag are in an α helix and a calcium-binding pocket, respectively (Figure 2a ), these insertions could be causing local disruption in structure, leading to the lower occupancy we observe (Table 1) . Additionally, position 277 is located near the pore of the hexamer, resulting in the five neighboring positions being between 1.4 and 2.8 nm away. Since the entire engineered linkage to mRFP1, i.e., (GSSG) 4 -SpyTag-SpyCatcher-mRFP1, is roughly 2.9 by 2.5 by 15 nm in dimensions, it is likely that some of the neighboring sites are sterically inaccessible once a single mRFP1 is bound. Further investigation will be required to untangle these possibilities.
Engineered C. crescentus Opens New Possibilities for Hierarchical Assembly of Hybrid Living Materials. The engineered S-layer system described here offers immediate opportunities for engineering enzyme cascades on cells and encapsulation in hydrogels. By eliminating the need for direct fusion of enzymes to the S-layer, we avoid potential enzyme activity inhibition caused by expressing the protein in tandem with the S-layer monomer. 52 In addition, the varied ligation density and SpyTag spatial positioning engineered in our strains provides flexibility to attach enzymes in the most ideal pattern. As another potential application, bacterial cells are frequently encapsulated in hydrogels to enhance their stability as probiotics, 53 as adjuvants to plant growth in agriculture, 54 or as biostimulants in wastewater treatment. 55 Typically no specific adherence mechanism is engineered between bacterial cells and the hydrogel, and many factors can affect gel stiffness, 56 including number or type of cells and media content. By using direct attachments between the S-layer and hydrogel polymers, we may achieve more stability and unique mechanical properties due to the sheer number of covalent cross-links the between the engineered S-layer and the hydrogel matrix.
Our work more broadly introduces several foundational aspects useful for engineering ELMs. First, our results (Figures 3, 5, 6) suggest any material on which SpyCatcher can be conjugated can be self-assembled on the modified 2D S-layer lattice, thus avoiding the labor-intensive reengineering of RsaA with peptides designed for specific targets. This makes our strain a versatile starting point for building an array of ELMs. Second, while ELMs with impressive functionality have been assembled via 1D curli fiber proteins and the type III secretion apparatus, 57 the 2D structure of the S-layer lattice yields another dimension of spatial control. Because hierarchical ordering underlies the exceptional physical properties of many natural biocomposites, the ability to regulate spacing of different components in multiple dimensions is key to rationally designing predictable ELMs. Third, we can attach materials densely to the cell surface; here we demonstrate ligation of ∼11 000 copies of a protein to the C. crescentus cell surface, or 1 attached protein per 288 nm 2 . This is the highest density of surface arrayed proteins reported on a bacterium to our knowledge. Being able to access high densities is important because it ensures well-ordered structures while the ability to tune density may result in control over material properties. Lastly, the combined robustness of the covalent SpyCatcher-SpyTag system, the RsaA S-layer, and C. crescentus enables long-term persistence of the assembled structure and cell viability in an ELM even under low aeration and nutrient conditions. We envision this robustness will enable ELMs that can function in nutrient-poor environments with minimal intervention. Thus, the RsaA platform described here offers a modular, stable platform for assembling materials densely in 2D that opens new possibilities for constructing ELMs.
■ CONCLUSIONS
In closing, hierarchically ordered hybrid materials could allow for the rational design of materials with the emergent properties seen in natural materials. A bottom-up approach toward these engineered living materials is controlled attachment of materials to the cell surface in 2D, which we achieved by engineering the C. crescentus S-layer with the Spy
ACS Synthetic Biology
Research Article conjugation system for specific attachment of hard, soft, and biological materials at controllable densities. This modular base could lead to higher ordered materials that combine the functions of inorganic materials with the self-assembly and selfhealing properties of living cells for applications that span medicine, infrastructure, and devices.
■ METHODS
Strains. All strains used in this study are listed in Table S1 . C. crescentus strains were grown in PYE media (0.2% peptone, 0.1% yeast extract, 1 mM MgSO 4 , 0.5 mM CaCl 2 ) at 30°C with aeration. E. coli strains were grown in LB media (1% tryptone, 0.5% yeast extract, 1% NaCl) at 37°C with aeration. When required, antibiotics were included at the following concentrations: For E. coli, 50 μg/mL ampicillin, 20 μg/mL chloramphenicol, 30 μg/mL kanamycin. For C. crescentus, 10 μg/mL (liquid) or 50 mg/mL (plate) ampicillin, 2 μg/mL (liquid) or 1 μg/mL (plate) chloramphenicol, 5 μg/mL (liquid) or 25 μg/mL (plate) kanamycin. Diaminopimelic acid (DAP) was supplemented at 300 μM and sucrose at 3% w/v for conjugation and recombination methods, respectively. All chemicals were purchased from Sigma-Aldrich or VWR.
Plasmid Construction. A list of all strains, plasmids, and primers used in this study is available in Tables S1−S3. Details on construction of p4B expression plasmids, pNPTS138 integration plasmids, and protein purification plasmids can be found in Supporting Information. Plasmids were introduced to E. coli using standard transformation techniques with chemically competent or electrocompetent cells, and to C. crescentus using conjugation via E. coli strain WM3064.
Genome Engineering of C. crescentus. The (GGSG) 4 -SpyTag-(GGSG) 4 sequence was integrated into the genomic copy of rsaA using a 2-step recombination technique and sucrose counterselection. The pNPTS-rsaA(SpyTag) integration plasmids were conjugated into C. crescentus CB15NΔsap and plated on PYE with kanamycin to select for integration of the plasmid. Successful integrants were incubated in liquid media overnight and plated on PYE supplemented with 3% (w/v) sucrose to select for excision of the plasmid and sacB gene, leaving the SpyTag sequence behind. Colonies were then spotted on PYE with kanamycin plates to confirm loss of plasmid-borne kanamycin gene. Integration of the SpyTag sequence and removal of the sacB gene was confirmed by colony PCR with OneTaq Hot Start Quick-Load 2× Master Mix with GC buffer (New England BioLabs) using a Touchdown thermocycling protocol with an annealing temperature ranging from 72°-62°C, decreasing 1°per cycle.
Successful RsaA-SpyTag protein expression was confirmed by band shift in whole cell lysate in Laemmli buffer and 0.05% 2-mercaptoethanol on a BioRad Criterion Stain-free 4−20% SDS-PAGE. The gel was UV-activated for 5 min before imaging on a ProteinSimple FluorChem E system. As RsaA was migrating higher than expected, Western blot was performed for confirmation. A Bio-Rad Trans-Blot Turbo system with nitrocellulose membrane was used to transfer protein from the SDS-PAGE gel and the membrane incubated in Thermo-Fisher SuperBlock buffer for 1 h. The protein of interest was first labeled during a 30 min incubation with Rabbit-C Terminal Anti-RsaA polyclonal antibody 58 (Courtesy of the Smit lab; 1:5000 in TBST, Tris-Buffered Saline with 0.1−0.05% Tween-20), followed by another 30 min incubation with Goat-Anti Rabbit-HRP (Sigma-Aldrich; 1:5000 in TBST). BioRad Precision Plus Protein Standards (Bio-Rad) were labeled with Precision Protein StrepTactin-HRP conjugate antibodies (Bio-Rad; 1:5000 in TBST). HRP fluorescence was activated with Thermo-Fisher SuperSignal West Pico Chemiluminescent Substrate and imaged in chemiluminescent mode. TBST washes were performed between each incubation step. The relative molecular weight of bands quantified against the BioRad Precision Plus Protein Standards using ProteinSimple's AlphaView software.
Monitoring Ligation of SpyCatcher-Fusions to C. crescentus. For flow cytometry experiments, cells were grown at 25°C to mid log phase and cells containing the pBXMCS-2-RFP plasmid were induced for 1−2 h with 0.03% xylose to serve as a positive control. A population of ∼10 8 cells (determined by optical density measurement where OD 600 of 0.05 contains 10 8 cells) were harvested by centrifugation at 8000 RCF for 5−10 min and resuspended in PBS + 0.5 mM CaCl 2 . Using the cell density as determined by OD 600 and assuming 4.5 × 10 4 RsaA monomers/cell, 33 we added SpyCatcher-mRPF1 to a final molar ratio of 1:20 RsaA protein to SpyCatcher-mRFP1. The reaction was then incubated for 1 h at room temperature with rotation. All samples were protected from light with aluminum foil during the procedure and washed twice with 1 mL of Phosphate-Buffered Saline (PBS) + 0.5 mM CaCl 2 buffer prior to imaging to remove any unbound protein. Cells were diluted to 10 6 cells/mL and analyzed on a BD LSR Fortessa. Data on forward scatter (area and height), side scatter, and PE Texas Red (561 mm laser, 600 LP 610/20 filter) was collected. A total of 150 000 events for each strain was measured over three experiments.
For each strain, the total population was gated using scatter measurements to remove events corresponding to aggregates and debris. All events from the resulting main population were used to create histograms of the fluorescence intensity of bound SpyCatcher-mRPF1 for each strain expressing RsaA (wild-type control) or RsaA-SpyTag ( Figure 4A ). These fluorescence intensity values were also used to calculate the absolute intensity of bound of SpyCatcher-mRFP1 for RsaA-SpyTag insertion location (I loc ) shown in Table 1 . The relative SpyCatcher-mRFP1 binding (I loc,rel ) was calculated by normalizing (I loc ) by the absolute intensity at location 467:
For confocal microscopy, cells were grown to mid log phase and ∼10 8 cells (again determined by OD 600 measurement) harvested by centrifugation at 8000 RCF for 5−10 min. They were then resuspended in PBS + 0.5 mM CaCl 2 and, as in the flow cytometry experiments, a 1:20 ratio of RsaA protein to fluorescent probe, i.e., mRFP1, SpyCatcher-mRFP1, SpyCatcher-ELP-mCherry, or ELP-mCherry was added. The reaction was then incubated for 1 h at room temperature with rotation for the mRFP1 probes and 24 h at 4°C for the ELP-mCherry probes. 2 × 10 7 cells were incubated with 100 nM QDs for 24 h at 4°C with rotation. All samples were protected from light with aluminum foil during the procedure and washed twice with 1 mL of buffer prior to imaging to remove any unbound protein. After the wash, cells with fluorescent probes were stained with 1 μM of DAPI (4′,6-diamidino-2-phenylindole). All samples were spotted onto agarose pads (1.5% w/v agarose in distilled water) and mounted between glass slides and glass coverslips. Immersol 518F immersion oil with a refractive index of 1.518 was placed between the sample and the 100× oil
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Research Article immersion objective (Plan-Apochromat, 1.40 NA) prior to imaging. Fluorescence and IRM images were collected using a Zeiss LSM 710 confocal microscope (Carl Zeiss Micro Imaging, Thornwood, NY) with the Zen Black software. For fluorescent imaging, a 561 nm laser was used for RFP/ mCherry excitation and 405 nm for DAPI. For IRM, a 514 nm laser was reflected into the sample using a mBST80/R20 plate, and then the reflected light was collected and imaged onto the detector. Images were false colored and brightness/contrast adjusted using ImageJ. 59 To quantify the binding of SpyCatcher-mRFP1 to RsaA-SpyTag, the same procedure was used as above except with a 1:2 ratio of RsaA to RFP was used and incubation for 24 h at 4°C with rotation. The reaction was visualized on a BioRad Criterion Stain-free 7.5% SDS-PAGE in Laemmli buffer with 0.05% 2-mercaptoethanol and the molecular weight of bands quantified against BioRad Precision Plus Protein Standards using Protein Simple's AlphaView software. The measurements were made in triplicate on two separate occasions, and all six results were averaged for the final percentage reported. For each experiment, the density of bands was measured using ImageJ. 59 Background subtraction was applied to the entire image, and the background-subtracted integrated density within an equal area was determined for each RsaA-SpyTag protein band. The integrated density of the bands from triplicate reactions lacking SpyCatcher were averaged to give I unreact . To calculate the percentage of RsaA 467 :SpyTag ligated to SpyCatcher-mRFP1 for each experiment, we calculated the difference in density between each RsaA-SpyTag band from reactions with SpyCatcher-mRFP1 (I react,1 , I react,2 , I react,3 ) relative to the unreacted control (I unreact ) and normalized this value by the unreacted control (I unreact ):
The reported value (P 467 ) is an average of the two experiments. We then used the absolute percentage of ligation at location 467 (P 467 ) and the relative binding of SpyCatcher-mRFP1 at each location to calculate the percentage of ligation for all the insertion positions.
The values of P loc are shown in Table 1 . Cell Viability Assay. Cell viability in the presence of SpyCatcher-QDs was determined using the viable plate count method. Approximately 4 × 10 8 mid log phase cells (day 0) (cell number determined by OD 600 measurement) were first incubated with 100 nM SpyCatcher-QDs in M2G buffer (1× M2 salts without NH 4 Cl to prevent extensive cell growth, 1 mM MgSO 4 , 0.5 mM CaCl 2 , 2% glucose) for 24 h at 4°C with rotation to allow QD ligation to the cell surface. Post binding (day 1), the cultures were transferred to a 25°C humidified incubator and left stationary for 2 weeks. Cultures were sampled at different time points (days 2, 7, and 14), serially diluted, and titered on PYE agar plates (0.2% peptone, 0.1% yeast extract, 1 mM MgSO 4 , 0.5 mM CaCl 2 , 1.5% agar), which were incubated at 30°C for 2 days. Colonies on the plates were counted and cell viability was quantified by enumeration of Colony Forming Units/mL as follows:
At the specified time points, 30 μL of culture was removed from the tube and centrifuged at 16 000g for 1 min. The supernatant was discarded and the cells were resuspended in 3 μL M2G buffer. A 1.5% agarose pad was prepared on a 25 × 75 mm glass slide and 0.6 μL of the resuspended culture was placed on it. An 18 × 18 mm coverslip was then placed on the pad, and the trapped cells were imaged and processed using as outlined above.
In Situ Atomic Force Microscope (AFM) Imaging. Mid log cultures of C. crescentus JS4038 carrying p4B-rsaA 600 , p4B-rsaA 600 467: (GGSG) 4 -spytag-(GGSG) 4 , or p4B-rsaA 600 690: (GGSG) 4 -spytag-(GGSG) 4 , were harvested at 8000 rpm for 5 min and the pellet resuspended in PBS + 5 mM CaCl 2 buffer. The JS4038 strain is defective in capsular polysaccharide synthesis. This is necessary for AFM imaging as the capsular polysaccharide layer obscures the S-layer lattice. The cells were washed three times to remove any debris. 100 μL of the washed cell culture was applied to a poly-L-lysine coated glass coverslip (12 mm cover glasses, BioCoat from VWR), which was premounted onto a metal puck. The sample was incubated at room temperature for 1 h to allow sufficient cell attachment, and then 1 mL of PBS + 5 mM CaCl 2 buffer was used to wash away unbound cells from the glass surface. 50 μL of PBS + 5 mM CaCl 2 buffer was added to the resulting glass surface, and the sample was transferred onto the sample stage for imaging.
In situ AFM imaging was performed on a Bruker Multimode AFM using PeakForce Tapping mode in liquid. An Olympus Biolever-mini cantilever (BL-AC40TS) was used for high resolution imaging. The following set of parameters was normally employed to ensure the best image quality: 0.2 to 0.5 Hz scanning rate, 512 × 512 scanning lines, 15 nm peak force amplitude, and 50 to 100 pN peak force set point.
The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acssynbio.8b00448.
Further methods on plasmid construction, protein purification, and QD synthesis (PDF)
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ACS Synthetic Biology
Research Article The rapid pace of increasing capabilities for bioengineering and synthetic biology has enabled dramatic improvements in our ability to design microorganisms as microscale factories to efficiently produce high value small molecules including pharmaceuticals, chemicals and commodity precursors. The value of capabilities for robust synthesis of diverse small molecules, including molecules not found in nature, is significant and warrants continued development. However, the synthetic capabilities of biology far exceed small molecules. Natural biological systems produce a dizzying array of higher order molecular assemblies at the mesoscale and beyond, often "cheating" thermodynamics to access disfavored material phases that require extreme processing conditions or are completely inaccessible via traditional materials synthesis routes. If we can harness the synthetic capabilities of biology to produce complex molecular assemblies and materials, we can revolutionize the production of structural materials. Engineered biological systems could be designed in which a single organism is programmed to produce a variety of products, each dependent on a specific input. This would enable a tunable materials synthesis platform in which different inputs drive the production of different output materials.
Sector: Transforming Cellular Factories with Synthetic Biology

Use Case for Cells as Factories: Temporally and Spatially Controlled Production of Structural Materials
Engineered microbes have potential to produce mesoscale materials of desired function beyond molecules. Microbes already produce structures such as carboxysomes. Once infected by phages, microbes produce virus or virus-like particles that could be potentially be co-opted to perform novel structural function. Exported mesoscale materials maybe engineered to interface with non-biological materials such as synthetic polymers, metals, minerals, semi-conductors, or carbonaceous materials. Engineered microbes themselves may be able to serve as a structural component of high-ordered material or devices beyond serving as biochemical factories. Significant effort is underway to engineer microbial ecosystem that can produce specific molecules and compounds but the challenges remain in using cells to produce mesoscale/supramolecular structures that may lead to direct interfacing with abiotic materials in temporally and spatially controlled manner. Phenotypes borrowed from extremophiles (such as chemolithotrophy, biostasis) may endow engineered microbes to perform new chemistry on queue while minimizing the loss of resources to biomass once optimal population for production has been achieved.
Desired outcome(s) that stretch current capabilities
• Tools for temporal control of cellular production • Engineered microbes that can produce and export variety of structural materials (e.g. magnetosomes, gas vesicles, virus-like particles) • Engineered extremophiles that are genetically facile or engineered lab strains to withstand extreme conditions • Tools for controlling multi-step reactions using co-cultures or community of microbes • Tools for spatial control of microbes
Sector: Transforming Cellular Factories with Synthetic Biology
Use Case for Cells as Factories: Temporally and Spatially Controlled Production of Structural Materials using Artificial Cells and Cell Free Systems
End Product: Structural materials produced via temporally and spatially controlled biological synthesis of mesoscale molecular structures Organism(s) if applicable: Various microbial organisms including archaea and extremophiles, mixed cultures, cell-free systems produced from these organisms, or artificial cells assembled from the bottom-up with isolated components from these organisms
The rapid pace of increasing capabilities for bioengineering and synthetic biology has enabled dramatic improvements in our ability to design microorganisms as microscale factories to efficiently produce high value small molecules. However, the synthetic capabilities of biology far exceed small molecules. While the engineering of living cells has already expanded our manufacturing capabilities and holds promise to revolutionize how we produce molecules and materials that impact multiple sectors spanning from medicine to textiles, living cells are inherently complex structures that have evolved to achieve outcomes that benefit the cell (reproduction, protection against threats, etc.). Engineering living cells has proven exceedingly difficult because it requires the modification of a system that is not fully understood, that is extraordinarily complex, that can function autonomously, that can exchange material with its environment, and that can evolve in response to external influences or threats. Living cells are also optimized to function in their natural environmental niche and are often unable to withstand dramatic shifts in temperature or environmental chemistry.
Artificial cells, non-living structures that are compatible with biological cellular machinery, or cell-free systems, either cell extracts or a collection of purified proteins/biomolecules, could provide a robust, predictable, non-autonomous platform for the execution of human-designed biological programs to realize novel material synthesis capabilities. Artificial cells and cell-free systems could serve as nonbiological reaction platforms that (i) sequester human-designed biological programs and the molecules needed to execute these programs, (ii) execute programs only when triggered, with no spurious activity and high signal to noise, (iii) can be stored in an inactive state for extended periods of time with highly reliable "re-boot" when needed, and (iv) are able to execute their programs over a wide range of environmental conditions.
For synthesis of complex biomolecular assemblies and mesoscale materials, artificial cells and cell-free systems may provide distinct advantages over living cells as manufacturing platforms. These systems may more readily accommodate production of complexes and materials of increased physical dimensions, as cell-free systems have no external bounds and the physical scale of artificial cells could be tuned based on the desired product. Moreover, concerns related to cell toxicity and cellular resource allocation are dramatically simplified in artificial cell and cell-free systems.
Desired outcome(s) that stretch current capabilities
• Integration of discrete artificial cell functions into coordinated artificial cell platforms • Optimization of cell-free systems to enable a robust, versatile manufacturing capability for mesoscale molecular structures and materials.
I n communities of single-celled and multicellular organisms, cell-cell communication enables cells to organize in space, distribute tasks, and to coordinate collective responses. Synthetic biologists have engineered living, communicating cells to form cellular patterns 1,2 and synchronize gene expression 3 but living systems are inherently challenging to study and engineer. Chemically constructed cell-mimics, as non-living, biochemically simplified and engineerable systems, could serve as models to study mechanisms of pattern formation and collective responses, and lead to the development of novel sensors and self-organizing materials. Important biochemical processes like protein synthesis 4,5 , DNA replication 6 , metabolism 7 , and cytoskeletal functions 8 have been reconstituted and studied in single synthetic cell-mimics. While biochemical reactions in microfluidic chambers [9] [10] [11] , in droplets 12, 13 and on beads 14 can emulate aspects of intercellular communication, studies on systems that structurally resemble natural cells with their semi-permeable membranes have been limited in scope by the availability of communication channels and assembly methods. Addressing the scalable assembly of artificial cells, microfluidic methods have been developed to mass-produce highly homogeneous populations of phospholipid vesicles encapsulating active biomolecules [15] [16] [17] [18] . Recent studies have demonstrated communication between synthetic microcompartments to induce gene expression 5, 13, 19, 20 or chemical reactions [21] [22] [23] using small molecule signals. To implement communication, signaling molecules must travel between compartments. Some small molecules diffuse freely between compartments 5, 13, [19] [20] [21] [22] , phospholipid vesicles can be permeabilized by inserting alpha-hemolysin pores 5, 23 , and other synthetic microcompartments such as gel-shell beads 24 , polymersomes 21 , proteinosomes 23 , and colloidosomes 22 can be assembled with permeable membranes. Signaling molecules for communication between artificial cell-mimics have so far been limited to small molecules. In contrast, signaling in multicellular organisms often involves secretion of proteins serving as growth factors or morphogens that provide cells with the information they need to develop into functional tissues 25 .
Here, we aim to expand the communication capabilities of artificial cells by developing a cellular mimic that produces and releases diffusive protein signals that travel in and get interpreted by large populations of cell-mimics. We describe the microfluidic production of cell-mimics with a porous polymer membrane containing an artificial hydrogel compartment, which resembles a eukaryotic cell's nucleus in that it contains the cell-mimics' genetic material for protein synthesis and can sequester transcription factors. Cell-mimics are able to communicate through diffusive protein signals, activate gene expression in neighboring cell-mimics, and display collective responses to cell-mimic density similar to bacterial quorum sensing.
Results
Porous cell-mimics containing artificial nuclei. We prepared porous cell-mimics capable of gene expression and communication via diffusive protein signals using a microfluidic method (Fig. 1a, b) . First, water-in-oil-in-water double emulsion droplets were formed in a polydimethylsiloxane (PDMS) device (Supplementary Figure 1, Supplementary Movie 1) . The droplets had a middle organic phase consisting of a 1-decanol and acrylate monomer solution and encapsulated DNA and clay minerals. Second, double emulsion droplets were collected and polymerized using UV light, inducing a phase separation of the inert 1-decanol to form porous microcapsules 26 . Third, following polymerization, we simultaneously permeabilized the polymer membrane and induced formation of a clay-hydrogel in their interior by adding a solution of ethanol and HEPES buffer. Membrane pores had diameters of 200-300 nm (Fig. 1a, Supplementary Figure 2 ). Polymer membranes were permeable to macromolecules up to 2 MDa but excluded 220 nm nanoparticles from about 90% of the microcapsules (Supplementary Figure 3) . Like in similarly prepared porous microcapsules 26, 27 , polymer membranes were mechanically stable and rigid. Microcapsules could be centrifuged at high speeds, and only broke under high stress from a razor blade ( Supplementary Figure 2) . The encapsulated clay minerals had a large capacity for binding and capturing DNA from solution, and retained DNA in the clay-DNA hydrogel that formed after electrolyte addition ( Supplementary Figure 4) 28 . During permeabilization of the polymer membrane with a solution of HEPES buffer and ethanol, the encapsulated clay minerals and DNA condensed into a round hydrogel structure in the microcapsules' interior that is analogous to the cell nucleus (Fig. 1c ). In at least 95% of microcapsules, only one clay-DNA hydrogel nucleus formed that measured approximately half of the microcapsules' diameter in size. In solution, not templated by a surrounding microcapsule, clay minerals form irregularly shaped and sized hydrogel particles (Supplementary Figure 5) . DNA adsorbs to the surfaces of clay minerals through electrostatic interactions, cation bridges, hydrogen bonding and ligand exchange [28] [29] [30] . Clay-DNA hydrogel nuclei had a porous structure, allowing macromolecules of up to 500 kDa to diffuse into the hydrogel while 2000 kDa dextran was partially excluded from hydrogel nuclei ( Supplementary Figure 3) . The permeability of the hydrogel nuclei to large macromolecules suggested that the DNA would be accessible to the transcription machinery. As a final step in the preparation of cell-mimics, we passivated their polymer membrane with polyethylene glycol (PEG) to prevent non-specific binding of proteins (Supplementary Figure 6) .
Gene expression in cell-mimics. The porous structure of the polymer membrane allowed supply of cell-free transcription and translation (TX-TL) reagents from the outside to induce synthesis of proteins encoded by the DNA in the cell-mimics' hydrogel nuclei. Even ribosomes, the largest components of TX-TL reagents, were able to diffuse into cell-mimics through their porous membranes ( Supplementary Figure 7) . To capture protein products within cell-mimics, we expressed a fusion protein of the tetracycline repressor TetR and sfGFP (TetR-sfGFP) as a fluorescent reporter. TetR binds the tet operator sequence (tetO). A coencapsulated 240 × tetO array plasmid localized the reporter protein to the hydrogel nucleus ( Fig. 1c ), which increased in fluorescence after TX-TL addition ( Fig. 1d , Supplementary Movie 2). Localization of TetR-sfGFP to the hydrogel nucleus was reversible and due to the specific interaction of TetR with tetO sites. Addition of anhydrotetracyline, which prevents TetR from binding DNA, caused a substantial unbinding of TetR-sfGFP. Without the tetO plasmid, fluorescence increased in solution but not in hydrogel nuclei ( Supplementary Figure 8) . In tetR-sfGFP/ tetO cell-mimics, fluorescence increased substantially in almost all cell-mimics ( Fig. 1e ). Variations in intensity were likely due to differences in DNA capture during formation of hydrogel nuclei ( Supplementary Fig. 5 ). Cell-mimics retained full expression capabilities after 2 years of storage, and separate batches showed comparable expression levels and dynamics ( Supplementary  Figure 9 ).
Protein exchange between cell-mimics. Due to their porosity, cell-mimics likely released mRNA and protein products that diffused into neighboring cell-mimics. To demonstrate that neighboring cell-mimics exchanged protein products with each other, we prepared sender cell-mimics, fluorescently labeled in their polymeric membranes and containing the tetR-sfGFP expression plasmid, and receiver cell-mimics containing the tetO array plasmid to capture the reporter protein. When both cellmimic types were mixed at approximately a one to one ratio, only the nuclei of the receiver cell-mimics increased in fluorescence ( Fig. 2a ). To explore how far TetR-sfGFP protein originating from a given sender cell-mimic travelled, we used a large excess of receivers and spread them densely into a circular 3.5 mm wide colony. Under these conditions, TetR-sfGFP spread from sender to surrounding receiver cell-mimics but stayed localized in patches around individual sender cell-mimics ( Fig. 2b , Supplementary Figure 10a ). This pattern of captured protein around source cell-mimics persisted for 24 h after expression ended, demonstrating that TetR-sfGFP was essentially trapped in the hydrogel nuclei once it was bound in the high local density of tetO sites. Assuming free diffusion, we would expect protein gradients to have disappeared within 5 h in similar geometries (Supplementary Figure 10b-d) .
To test the preference of a given cell-mimic to bind protein originating from its own DNA, we prepared tetR-mCherry / tetO cell-mimics that accumulated red fluorescence in their hydrogel nuclei ( Supplementary Fig. 10 ). When mixed with tetR-sfGFP / tetO cell-mimics (Fig. 1c) , there was essentially no difference in relative fluorescence in either channel between the cell-mimic types, indicating that in close proximity, neighboring cell-mimics completely exchanged protein products ( Supplementary Figure 11 ). While transcription occurred in the hydrogel nuclei where DNA was localized, these results indicate that translation was likely not localized to the cell-mimic a given mRNA originated from. However, because mRNA lifetime in TX-TL reagents is short, and mRNA thus has a limited diffusion range, we expected the localization of TetR-sfGFP and TetR-mCherry to depend strongly on distance between cell-mimics. We distributed the two cell-mimic types in a reaction chamber so that they mixed in the center but remained separate on either side. Cell-mimics in the center showed mixed fluorescence while cell-mimics on the sides fluoresced primarily in one channel (Fig. 2c) , demonstrating that locally, on the order of few cell-mimic lengths, proteins exchanged with little hindrance by the polymer membranes, whereas exchange of protein with distant cell-mimics was limited by diffusion.
Communication through a diffusive transcriptional activator. Communication in vesicle-based cell-mimics has so far been limited to small molecule signals such as quorum sensing molecules 19, 20 or IPTG and glucose, combined with membrane pores, like alpha-hemolysin 5, 23 . Our porous cell-mimics exchanged proteins with their neighbors, suggesting they are able to communicate with each other directly through genetic regulators. To demonstrate this we constructed a two-stage activation cascade and distributed the network into two separate cell-mimic types. T3 RNA polymerase (T3 RNAP) served as a diffusive signaling molecule transmitting the instruction to express a reporter gene from activator to reporter cell-mimics. Activator cell-mimics contained the template for the expression of T3 RNAP. Reporter cell-mimics contained the template for the T3 RNAP-driven synthesis of the TetR-sfGFP reporter as well as tetO array plasmids to capture the reporter protein. When both cellmimic types were mixed, reporter cell-mimics expressed and bound the fluorescent reporter ( Fig. 3, Supplementary Movie 3) , while activator cell-mimics alone did not increase in fluorescence ( Supplementary Figure 12) .
Artificial quorum sensing. We hypothesized that T3 RNAP could serve as a soluble signaling molecule providing cell-mimics with information about population density. Indeed, cell-mimics containing both the activation circuit and reporter constructs (Fig. 4a ) underwent a collective response where fluorescence accumulated in cell-mimics only at high densities. At low cellmimic densities, signals from the hydrogel nuclei were not detectably different from background fluorescence (Fig. 4b) . We titrated the density of cell-mimics in a fixed volume and found a sharp transition from off to on, which resembled bacterial quorum sensing responses to cell density 31 even though, unlike in bacterial quorum sensing mechanisms, the T3 activation circuit did not contain positive feedback. The threshold cell-mimic density at which expression of the reporter turned on was 400 cell-mimics in 4.5 µl TX-TL (Fig. 4c ). Cell-mimics that constitutively expressed the reporter (Fig. 1c ) accumulated fluorescence in their hydrogel nuclei regardless of their density (Supplementary Figure 13 ). The collective response to density can be explained by T3 RNAP release from cell-mimics. At low densities, T3 RNAP is diluted in the comparably large volume of the sample, while at high density a sufficient concentration of transcriptional activator accumulates to turn on expression of the reporter. Titrating the T3 RNAP template DNA in TX-TL reactions, we found a steep transition from low to high expression with a half-maximal activation at 10 pM ( Supplementary Figure 14) . The calculated bulk concentration of T3 RNAP template in an artificial quorum sensing experiment at the threshold density of 400 cell-mimics per droplet is 12.5 pM, similar to the activation threshold in bulk solution.
During development, cells interpret signals secreted by their neighbors to differentiate into specialized cell-types that express different sets of genes 25 . We aimed to emulate cellular differentiation according to local environment by combining the artificial quorum sensing network with a constitutively expressed tetR-mCherry reporter that turns on irrespective of cell-mimic density (Fig. 4d ). We distributed cell-mimics unevenly in a long narrow reaction chamber (Fig. 4e) , and analyzed the fluorescence of individual hydrogel nuclei according to their location in the density gradient. While absolute fluorescence intensities and background fluorescence increased with cellmimic density, hydrogel nuclei from the high density area displayed visibly higher sfGFP:mCherry ratios than hydrogel nuclei in the dilute region that primarily displayed mCherry fluorescence (Fig. 4f ). In the continuous density gradient, we observed some graded responses in the center of the chamber at medium density. However, plotting sfGFP against mCherry fluorescence for individual hydrogel nuclei revealed two distinct populations of fluorescence signals according to position in the chamber (Supplementary Figure 15 ).
Discussion
We developed porous cell-mimics capable of gene expression and communication via diffusive protein signals. The clay-DNA hydrogel in the cell-mimic's interior resembles a eukaryotic cell's nucleus, and represents a different strategy to compartmentalize artificial cells 17, 32, 33 . Our study demonstrates that clay minerals and clay-DNA hydrogels are useful hybrid materials for synthetic biology and the assembly of artificial cell-mimics. In fact, clay minerals have been proposed as favorable environments for prebiotic evolution because a wide variety of organic molecules adsorbs to their surface. Clay minerals have been shown to possess catalytic properties 34 and to enhance protein synthesis in cell-free expression systems 28 . Unlike lipid vesicles that require careful matching of osmolarities and gentle separation techniques, the cell-mimics reported here with their porous polymer membranes were physically highly stable, easily transferred into new media by centrifugation, and retained full expression capabilities after 2 years of storage. Microfluidic production of highly homogeneous cell-mimics will facilitate studies requiring large quantities of cell-mimics as our results on spatially arrayed, communicating cell-mimics demonstrate. Passivating cellmimics' polymer membranes with PEG, we showed that their membranes could be chemically modified, which will allow further functionalization, for example, for immobilization on substrates, to target specific proteins to the membrane or to tune membrane permeability. So far, communication in synthetic, non-living cell-mimics has been limited to small molecule signals 5, 19, 20, 22, 23 . The porous cellmimics developed here expand the communication capabilities of artificial cells to large macromolecules like RNAs and proteins. We showed that genetic circuits could be distributed into separate cell-mimics, which allowed them to share tasks. Such modularity might facilitate the assembly of functional, distributed gene circuits by titrating cell-mimics containing different parts of a network. Furthermore, individual components of circuits located in different cell-mimics can be spatially organized to generate spatiotemporal expression patterns. Protein signals play an important role for cell-cell communication in multicellular organisms, where cells release and receive protein signals in the form of hormones, growth factors, and morphogens 25 . We believe that reaction-diffusion models explaining developmental processes in multicellular organisms may be tested and emulated in artificial, tissue-like arrangements of cell-mimics even when they are composed of unnatural materials, operate on different scales and with different molecular mechanisms. Clearly, a major difference between an artificial tissue assembled from porous cell-mimics and natural tissues is that translation of proteins takes place both inside and outside of the cell-mimic a given mRNA originates from, and that mRNAs and proteins can freely diffuse. In this regard, our system emulates features of the syncytium stage during Drosophila embryogenesis, when thousands of nuclei accumulate in the unseparated cytoplasm of the oocyte 35 . In another analogy to this developmental stage, we showed trapping of the TetR transcription factor in nuclei containing binding sites. Nuclear trapping is a mechanism that is responsible for establishing sharp gradients of phosphorylated ERK/MAPK (dpERK) across the syncytical Drosophila embryo by limiting diffusion of dpERK 36 . In future work, diffusion rates of proteins through tissue-like arrangements of cell-mimics may be tuned by using nuclear binding sites that restrict diffusion of DNA binding proteins or by modifying polymer membrane permeability.
A genetic activation circuit led to a remarkable collective response to cell-mimic density, which resembled bacterial quorum sensing. In contrast to bacterial quorum sensing 31 , the mechanism of our artificial quorum sensing involved no positive feedback loop and employed a protein instead of a small molecule, showing that artificial cells can emulate biological phenomena using unnatural parts and mechanisms. Several molecular mechanisms can produce cooperative or ultrasensitive behaviors 37 . Polyvalent interactions enhance functional affinities between binding partners by favoring ligand rebinding after an initial binding event occurred [37] [38] [39] . We believe the switch-like behavior of the artificial quorum sensing response is due to cooperative binding of the T3 RNAP to highly polyvalent hydrogel nuclei containing high local concentrations of T3 RNAP promoters, combined with large distances between cell-mimics at low densities ( Supplementary Figure 16) , and an already sigmoidal response curve to T3 RNAP template concentration ( Supplementary Figure 14) . Collective responses can lead to greater accuracy and reduce noise 3 , which will be particularly helpful for the assembly of reliably functioning cell-mimics, which often suffer from variability in gene expression 5, 40 .
In conclusion, our system has a number of potential uses, including programming cell-mimics to collectively sense and respond to their environment. Indeed, artificial cell-mimics could be used to develop sensors and self-organizing materials, as well as being arrayed into synthetic tissues of artificial cells, which could serve as simplified models for reaction-diffusion processes.
Methods
Fabrication of microfluidic chips. PDMS devices were prepared by standard soft lithography methods to produce devices with a design as shown in Supplementary Figure 1 . A silicon wafer patterned with SU-8 photoresist served as a mold for PDMS devices. The mold was prepared following standard photolithography procedures to produce a feature height of 43 µm. Design of the flowfocusing junction was adapted from Desphande et al. 16 ( Supplementary Figure 1) . PDMS (Sylgard, Dow Corning) was prepared at a 1:10 ratio and cured for 1 h at 80°C. PDMS devices were bonded to PDMS spincoated cover glass using oxygen plasma (50 watt for 30 s at 0.45 torr). After bonding, devices were baked overnight at 120°C to recover hydrophobicity. Channels downstream of the flow-focusing junction were rendered hydrophilic by a treatment with a 5% (wt/vol) polyvinyl alcohol (PVA) solution 16 , which was flowed in the inlet for the outer aqueous solution for 5 min while blowing air into the other inlets to avoid contact of the PVA-solution with device regions upstream of the flowfocusing junction. The remaining PVA-solution was removed by applying vacuum to the outlet. Following PVA-treatment devices were baked again for 2 h at 120°C and used immediately or stored for up to 2 months.
Production of porous cell-mimics with DNA-hydrogel nuclei. 2% (wt/vol) Laponite XLG (BYK Additives) clay stock was prepared by mixing 10 ml of ultrapure H 2 O on a magnetic stir plate to create a vortex. 200 mg of Laponite XLG were slowly added into the vortex and left to stir for 2 h until clear. The dispersion was then stored at 4°C and used for up to a week. Photoinitiator 2,2-dimethoxy-2phenylacetophenone was dissolved at 5% (wt/vol) in 1-decanol and in Trimethylolpropane ethoxylate triacrylate (ETPTA, Sigma-Aldrich, Mn 428). ETPTA with photoinitiator was stored at 4°C and used for up to a week. Double emulsion droplets were prepared with an inner aqueous solution (IA) containing 0.4% (wt/ vol) laponite XLG, 15% (vol/vol) glycerol, 50 mg/ml poloxamer 188, 20 µM sulfo-Cy5 and up to 300 ng/µl plasmid or linear DNA. The middle organic phase (MO) was composed of glycidyl methacrylate (GMA, Sigma-Aldrich), ETPTA, and 1decanol at a 48:32:20 ratio and contained 2.6% (wt/vol) photoinitiator and 0.25% (vol/vol) Span-80 to produce porous microcapsules 26 . For fluorescently labeled microcapsule membranes, the MO phase contained 0.1 mg/ml methacryloxyethyl thiocarbamoyl rhodamine B. The outer aqueous phase (OA) was 15% (vol/vol) glycerol with 50 mg/ml poloxamer 188.
Using syringe pumps, the three phases were flowed through the microfluidic device at speeds of 3 to 12 µl/h for the IA, 30 to 70 µl/h for the MO and 250 to 500 µl/h for the OA phase. Flow rates were adjusted to produce a stable formation of double emulsion droplets and then left unchanged for collection of droplets. Typically, about 200 µl of double emulsion were collected from the chip. The emulsion was then placed in a 2 mm thick chamber built from cover glass and exposed to 350 nm UV light for 30 s using a UV reactor (Rayonet). The dispersion of polymerized microcapsules was then added to 2 ml solution of 70% Ethanol containing 200 mM HEPES pH 8 to permeabilize the shell and to form the DNA-clay-hydrogel nucleus. This stock was stored at −20°C until use.
To prevent non-specific binding of proteins to porous polymer membranes, microcapsules were treated with polyethylene glycol (PEG). We coupled amino-PEG12-alcohol to the epoxide functionalities on the polymer shells. First, microcapsules were washed with 200 mM sodium carbonate buffer pH 10 by centrifugation. All supernatant was removed from the capsule pellet and a solution of 250 mM amino-PEG12-alcohol in 50% ethanol pH 10 was added to the pellet. Microcapsules were incubated at 37°C for reaction overnight and then washed with 100 mM HEPES pH 8. These PEGylated cell-mimics were either used directly or stored in 70% ethanol 200 mM HEPES pH 8 at −20°C.
DNA templates. Plasmids used in this study are listed in Supplementary Table 1 . Plasmid DNA was purified using the NucleoBond Xtra Midi kit (Macherey-Nagel), followed by an isopropanol precipitation and resuspension of the DNA pellet in ultrapure H 2 O to prepare highly concentrated plasmid stocks and maximize expression in TX-TL reactions. The template for T3 RNA polymerase was on linear DNA prepared by PCR from a plasmid template. DNA template concentrations encapsulated in cell-mimics are listed in Supplementary Table 2 .
Cell-free transcription and translation reactions. E. coli lysate for TX-TL reactions was prepared by freeze-thawing from E. coli BL21-Gold (DE3)/pAD-LyseR 41 . To induce T7 RNA polymerase activity besides E. coli RNA polymerase activity the main culture was induced with 0.5 mM IPTG an optical density measured at 600 nm (OD 600 ) of 0.5-0.6. Cells were harvested by centrifugation at an OD 600 of 1.4 and resuspended in ice cold S30A buffer (14 mM magnesium glutamate, 60 mM potassium glutamate, 50 mM Tris, pH 7.7). Cells were again pelleted by centrifugation, and after determining pellet mass, cells were resuspended in two volumes (relative to cell mass) of S30A buffer containing 2 mM DTT and frozen at −80°C. For lysate preparation, cells were thawed, vigorously vortex mixed for 3 min and incubated on an orbital shaker at 300 rpm at 37°C for 45 min. Cell suspensions were again vortex mixed and incubated for another 45 min under shaking at 37°C. Following incubation, cells were again vigorously mixed and the lysate was cleared by centrifugation at 50,000×g for 45 min. Cell debris-free, clear supernatant was collected and frozen in aliquots at −80°C until use. For the final composition of TX-TL reactions, cell lysate was diluted 2.5-fold with reaction buffer, microcapsules or DNA, and other additions as needed. This resulted in the following concentrations in the TX-TL reaction: 4.6 mg/ml protein, 7 mM Mg-glutamate, 60 mM K-glutamate, 3.5 mM DTT, 0.75 mM each amino acid except leucine, 0.63 mM leucine, 50 mM HEPES, 1.5 mM ATP and GTP, 0.9 mM CTP and UTP, 0.2 mg/ml tRNA, 0.26 mM CoA, 0.33 mM NAD, 0.75 mM cAMP, 0.068 mM folinic acid, 1 mM spermidine, 30 mM 3-PGA, 3.5% PEG-8000. When linear DNA templates were used, they were stabilized by adding 4 µM of chi6 duplex DNA to the TX-TL reaction 42 . TX-TL reactions were incubated at 29°C for expression.
Gene expression in cell-mimics. For cell-mimics, expression reactions typically consisted of 1 µl concentrated cell-mimics in 100 mM HEPES pH 8 and TX-TL reagents for a final volume of 5 µl. Droplets of 4.5 µl of this mixture were pipetted onto a 35 mm Lumox dish (Sarstedt). The gas permeable substrate ensured homogeneous sfGFP expression in the sample. The cell-mimic droplet was covered with cover glass and sealed with a ring of vacuum grease to prevent evaporation and provide a spacer. The reaction volume was scaled up for experiments in larger samples, and was 20 µl in Fig. 2b and 35 µl for long, narrow reaction chambers in Figs. 2c and 4e . Long, narrow reaction chambers were made from two parallel 20 mm lines of vacuum grease with a gap of 2 mm, which was filled with TX-TL and cell-mimics and then sealed with cover glass.
Preparation of labeled ribosomes. E. coli ribosomes (New England Biolabs) were incubated in labeling buffer (50 mM HEPES pH 8.2, 100 mM KCl, 10 mM magnesium acetate) with a molar excess of Alexa Fluor 488 NHS Ester (ThermoFisher Scientific) for 90 min at room temperature. Free dye was removed by washing with labeling buffer in centrifugal filter devices with a molecular weight cut-off of 100 kDa. Each ribosome contained approximately eleven Alexa Fluor 488 labels.
Plate reader reactions. Plate reader reactions were performed in 384-well plates using a 10 µl reaction volume covered with 10 µl light mineral oil in a Tecan infinite F200 plate reader. GFP fluorescence was read every 5 min using a 485 nm ± 20 nm excitation filter and a 550 nm ± 35 nm emission filter, followed by 1 min of shaking.
Fluorescence intensity measurements were calibrated using purified sfGFP-His 6 to determine absolute concentrations.
Imaging and image analysis. Images were acquired using a spinning disk confocal microscope consisting of a Yokagawa spinning disk system (Yokagawa, Japan) built around an Axio Observer Z1 motorized inverted microscope (Carl Zeiss Microscopy GmbH, Germany) with a 20 × 1.42 NA objective. Large regions were imaged as tiles and stitched using ZEN Blue software. Further image processing and analyses were done in Fiji/ImageJ 43 . Fluorescence traces or endpoint intensities of individual hydrogel nuclei were extracted from timelapse movies by measuring fluorescence in manually selected oval regions in nuclei, using a non-fluorescent region in each cell-mimic for background subtraction. Artificial quorum sensing data was analyzed using the colony counter plugin in Fiji/ImageJ to segment and count cell-mimics and polymer beads in the stitched brightfield image of a droplet. When necessary, regions of interest were manually added or deleted. Fluorescence values of individual cellmimics were mean fluorescence values of the individual segmented cell-mimics. For background correction, fluorescence values of segmented regions from each droplet were sorted. The lowest fluorescence intensities were from solid polymer beads, and we used this property for background correction. We removed the lowest 34% of values, which was the percentage of polymer beads in the sample, and used the highest of the removed values for background subtraction of the reduced list. Experiments (droplets with different amounts of cell-mimics) were performed for densities between 25 and 800 cell-mimics per droplet, which were binned every 50 cell-mimics. Each bin contained data from at least 156 analyzed cell-mimics.
Scanning electron microscopy was performed with a Zeiss SIGMA VP field emission scanning electron microscope using air-dried cell-mimics. To image cross sections of microcapsule polymer membranes, cell-mimics were cut using a razor blade.
Data availability
The authors declare that all relevant data supporting the findings of this study are available within the paper and its Supplementary information files. Additional data are available from the corresponding author upon request. Cell-free protein synthesis has emerged as a powerful approach for expanding the range of genetically encoded chemistry into proteins. Unfortunately, efforts to site-specifically incorporate multiple non-canonical amino acids into proteins using crude extract-based cell-free systems have been limited by release factor 1 competition. Here we address this limitation by establishing a bacterial cell-free protein synthesis platform based on genomically recoded Escherichia coli lacking release factor 1. This platform was developed by exploiting multiplex genome engineering to enhance extract performance by functionally inactivating negative effectors. Our most productive cell extracts enabled synthesis of 1,780 ± 30 mg/L superfolder green fluorescent protein. Using an optimized platform, we demonstrated the ability to introduce 40 identical p-acetyl-L-phenylalanine residues site specifically into an elastin-like polypeptide with high accuracy of incorporation ( ≥ 98%) and yield (96 ± 3 mg/L). We expect this cell-free platform to facilitate fundamental understanding and enable manufacturing paradigms for proteins with new and diverse chemistries. DOI: 10.1038/s41467-018-03469-5 OPEN C ell-free synthetic biology is emerging as a transformative approach to understand, harness, and expand the capabilities of natural biological systems 1 . The foundational principle is that complex biomolecular transformations are conducted without using intact cells. Instead, crude cell lysates (or extracts) are used, which provides a unique freedom of design to control biological systems for a wide array of applications. For example, cell-free protein synthesis (CFPS) systems have been used to decipher the genetic code 2 , prototype genetic circuits and metabolic pathways [3] [4] [5] [6] [7] , enable portable diagnostics 8 , facilitate ondemand biomolecular manufacturing 9,10 , and produce antibody therapeutics at the commercial scale 11 . The recent surge of applications has revitalized interest in cell-free systems, especially in areas where limits imposed by the organism may impede progress. One such area is expanding the genetic code to incorporate non-canonical amino acids (ncAAs) into proteins, where the extent of engineering can be limited by the fitness of the organism [12] [13] [14] [15] .
Pioneering efforts by Schultz and others have demonstrated it is possible to genetically encode more than 150 ncAAs into proteins, and that this encoding can be a powerful tool 15, 16 . For example, site-specific incorporation of ncAAs at single positions in proteins have provided new ways to study protein structure, dynamics, and posttranslational modifications 17 , as well as manufacture protein-drug conjugates 18, 19 . However, inefficiencies associated with the engineered orthogonal translation (TL) machinery (e.g., TL elements that specifically use a ncAA and do not interact with the cell's natural TL apparatus) have limited the ability to incorporate multiple ncAAs into proteins with high purity and yields 20, 21 . A key constraint is that codon reassignment strategies typically rely on amber suppression 22 , where the amber UAG stop codon is re-assigned to encode a ncAA and the orthogonal transfer RNA anticodon is mutated to CUA. The orthogonal ncAA-tRNA CUA must then outcompete essential TL machinery (e.g., release factor 1, RF1) for the UAG codon. Historically, this competition has led to poor protein expression yields, as premature termination by RF1 exponentially increases with the number of amber codons in the coding sequence 23 . Poor protein expression yields limit applications in both basic and applied science.
Recently, a genomically recoded Escherichia coli strain was developed (C321.ΔA) in which all 321 occurrences of the UAG stop codon were reassigned to the synonymous UAA codon 24 using multiplex automated genome engineering (MAGE) 25 and conjugative assembly genome engineering (CAGE) 26 . This allowed for the genomic deletion of RF1 (i.e., ΔprfA or ΔA) without affecting cellular physiology, thus freeing the UAG codon for dedicated ncAA incorporation 24 . Precursor RF1-deficient strains in which only a small set of essential genes were recoded have already shown the potential to produce proteins with improved ncAA incorporation efficiencies as compared with strains with RF1 24, 27 ; however, the upregulation of natural suppression mechanisms (e.g., ssrA) is problematic, because they promote the formation of truncation products, especially for tens of incorporation events 24, 27, 28 . The fully recoded C321.ΔA strain avoids these problems and we recently showed the possibility of using C321.ΔA coupled with extensively engineered synthetases for multi-site incorporation of up to 30 ncAAs into a single biopolymer in vivo 20 . Based on these results, we hypothesized that the fully recoded C321.ΔA strain would serve as an ideal chassis strain for the development of crude extract-based cell-free systems capable of highly efficient, multi-site ncAA incorporation into biopolymers. Such a system would complement in vivo manufacturing strategies, with some advantageous features 29, 30 . For example, the open reaction environment means the supply of orthogonal TL system (OTS) components and their substrates necessary for high-level ncAA incorporation can be provided and controlled at precise ratios as a way to overcome enzyme inefficiencies. In addition, cell-free systems are not limited by viability requirements, thus avoiding constraints arising from toxic OTS components 27 . Our proposed approach based on the C321.ΔA strain might also provide cost and ease of use advantages over other cell-free systems that have tried to reduce the effects of RF1 competition by using reconstituted systems 31 , antibody inhibitors 32 , RF1 depletion by subtractive chromatography 33 , or partially recoded E. coli strains with elevated natural suppression mechanisms 34 .
Here we describe the development of a CFPS platform from the genomically recoded C321.ΔA to manufacture proteins with tens of identical site specifically introduced ncAAs. Specifically, we use MAGE to improve protein production capacity by inactivating negative effectors in the host strain such that they are not present in the lysate. By testing tens of strain variants, we isolate a CFPS platform capable of synthesizing 1,780 ± 30 mg/L of superfolder green fluorescent protein (sfGFP), as well as modified sfGFP containing up to five p-acetyl-L-phenylalanine (pAcF) residues at high purity ( ≥ 98%). Using an optimized CFPS platform, we test the ability to synthesize elastin-like polypeptides (ELPs) that 
Results
CFPS from extracts of a genomically recoded organism. To benchmark CFPS activity, we first compared sfGFP yields in extracts from C321.ΔA and BL21 Star (DE3), the standard commercial protein expression strain (Fig. 1a ). Combined transcription (TX)-TL reactions were carried out in 15 µL volumes for 24 h at 30°C. Protein yields from BL21 Star (DE3) extracts were > 3fold higher than those from C321.ΔA (Fig. 1b) , highlighting the need to improve protein synthesis yields to take advantage of the benefits of RF1 removal for making modified proteins with ncAAs for preparative purposes. Previously, genomic modifications to the extract source strain to stabilize DNA template 35 , amino acid supply 36 , and protein degradation 37 have improved CFPS yields from other source strains. For example, we engineered a partially recoded strain of E. coli (rEc.E13.ΔA) by disrupting genes encoding nucleases (MCJ.559 (endA − csdA − )) to improve protein synthesis yields > 4-fold relative to the parent strain 34 . Building on this knowledge, we hypothesized that the genomic disruption of negative protein effectors in C321.ΔA extracts would help stabilize essential substrates in cell-free reactions, extend reaction durations, and increase CFPS yields.
Strain engineering for improved CFPS performance. We targeted the functional inactivation of five nucleases (rna, rnb, mazF, endA, and rne), two proteases (ompT and lon), and eight targets shown previously to negatively impact amino acid, energy, and redox stability (gdhA, gshA, sdaA, sdaB, speA, tnaA, glpK, and gor) in C321.ΔA individually and in combination (Supplementary Table 1 ). Our effort followed a five-step approach. First, we generated a library of single mutant strains in which we used MAGE to insert an early TL termination sequence into the open reading frames of gene targets that would functionally inactivate them, as we have done before 34 ( Fig. 2a and Supplementary  Tables 2 and 3 ). Second, we confirmed gene disruptions using multiplex allele specific PCR and DNA sequencing. Third, we measured the growth rate for each of the MAGE-modified strains, noting that average doubling time increased 9 ± 9% above the parent strain ( Supplementary Table 4 ). Fourth, cell extracts from each strain were generated using a high-throughput and robust extract generation procedure 38 . Fifth, we tested the strains in CFPS to assess their overall protein synthesis capability. We observed that seven single functional inactivation mutations increased CFPS yields more than 50% relative to the wild type C321.ΔA strain; namely, rne − , mazF − , tnaA − , glpK − , lon − , gor − , and endA − (Fig. 2b) . These results suggested that some of the protein effectors targeted for inactivation were deleterious to CFPS activity. They also demonstrated the difficulty associated with predicting CFPS productivities from engineered strains. For example, some mutations identified in previous screens (e.g., rnb − in rEc.E13.ΔA) 34 were not beneficial in the C321.ΔA context, others which reduced cellular fitness enhanced CFPS activity (e.g., lon − ), and yet others with no impact on cell growth (e.g., ompT − ) led to poor extract performance (Fig. 2b) .
With improvements in hand from single mutant strains, we next set out to identify synergistic benefits to CFPS productivity by combining highly productive mutations. We introduced the rne − , mazF − , tnaA − , glpK − , lon − , and gor − mutations to the best performing strain from our initial screen, strain C321.ΔA.542 (endA − ) (Fig. 2c ). The combination of endA − and gor − mutations resulted in an extract capable of synthesizing 1,620 ± 10 mg/L of active sfGFP (strain C321.ΔA.709). We then used C321.ΔA.709 to generate six additional strains with combined mutations. Although we did not observe synergistic enhancements, our top performing extract chassis strain (C321.ΔA.759 (endA − gor − rne − mazF − )) resulted in total yields of 1,780 ± 30 mg/L (Fig. 2d) , representing a 4.5-fold increase in sfGFP yield relative to the progenitor strain (C321.ΔA). In addition, we tested 12 combinatorial mutants generated throughout our MAGE screening, and although a few demonstrated CFPS yields > 1 g/L of active sfGFP, none surpassed the CFPS yields observed from C321.ΔA.759 ( Supplementary Table 5 ). Lastly, we determined that CFPS improvements seen in C321.ΔA.759 brought on by genomic modifications could not be obtained by simply supplementing C321.ΔA-based reactions with RNAse inhibitors ( Supplementary  Fig. 1 ). Final strains were fully sequenced to verify functional targeted modifications in the genome. Whole-genome sequences for strains C321.ΔA, C321.ΔA.542, C321.ΔA.705, C321.ΔA.709, C321.ΔA.740, and C321.ΔA.759 have been deposited in the NCBI SRA collection under accession code PRJNA361365. Each of the targeted mutations were achieved. MAGE has been shown to induce mutations throughout the genome before, and we observed a number of accumulated polymorphisms in the extract chassis strains. These polymorphisms, along with a specific list of protein-coding genes bearing mutations, are shown in Supplementary Tables 6 and 7 . In the future, we seek to better understand the systems impact of the non-targeted mutations. Based on our previous studies using rEc.E13.ΔA [34] , we hypothesized that the beneficial mutations in C321.ΔA.759 reduced messenger RNA degradation and stabilized the DNA template. To test mRNA stability, we performed TL-only reactions using extracts derived from C321.ΔA.759 and C321.
ΔA. Purified mRNA template coding for sfGFP was used to direct protein synthesis. We observed a twofold increase in mRNA and 90% increase of active sfGFP using C321.ΔA.759 extracts relative to C321.ΔA extracts after a 120 min cell-free reaction ( Supplementary Fig. 2 ). To test DNA stability, TX-only reactions were used. Specifically, plasmid DNA containing the modified red fluorescent protein-Spinach aptamer gene (Supplementary Table 3 ) was pre-incubated with cell extract and a fluorophore molecule, 3,5-difluoro-4-hydroxybenzylidene imidazolinone (DFHBI), for 0, 60, and 180 min. Then, CFPS reagents were added and mRNA was synthesized, then quantified by measuring the fluorescence of DFHBI-bound Spinach aptamer mRNA. After 180 min of pre-incubation, nearly 50% of Spinach aptamer mRNA was synthesized in C321.ΔA.759 (endA − ) extracts relative to the 0 min control. In contrast, the extract with endonuclease I (C321.ΔA) decreased the maximum mRNA synthesis level by7 5% ( Supplementary Fig. 3 ). Together, our data support the hypothesis that inactivating nucleases in the extract chassis strain stabilized DNA and mRNA to improve CFPS yields.
In addition to confirming added DNA and mRNA stability, we also assessed potential changes in energy and amino acid substrate stability that may have occurred in C321.ΔA.759relative to C321.ΔA-based CFPS. Similar trends in ATP levels ( Supplementary Fig. 4 ), adenylate charge ( Supplementary Fig. 5 ), and amino acid concentrations ( Supplementary Fig. 6 ) were observed in CFPS reactions derived from both strains. Supplemental feeding with the amino acids found to be most rapidly depleted did not improve yields ( Supplementary Fig. 6f ). The similar amino acid and energy stability profiles in C321.ΔA.759 compared with C321.ΔA suggest that our strain engineering efforts did not modulate the availability of these substrates.
To generalize CFPS improvements in C321.ΔA.759, we next expressed four model proteins that have been previously synthesized in CFPS systems and compared productivities to BL21 Star (DE3). We observed a 31-63% increase in soluble and total protein synthesis of sfGFP, chloramphenicol Supplementary Fig. 8 shows the entirety of the autoradiogram along with a molecular weight marker. b Multi-site incorporation of pAcF into sfGFP variants as quantified by active protein produced. The sfGFP variants used were wild-type (WT), sfGFP containing a single pAcF corresponding to the position of T216 (1 UAG), sfGFP containing sfGFP containing two pAcFs (2 UAG), and sfGFP containing five pAcFs (5 UAG). Three independent batch CFPS reactions were performed for each sample at 30°C for 20 h (n = 3). Error bar = 1 SD. c Spectrum of the 28 + charge state of sfGFP, obtained by top-down mass spectrometry and illustrating sitespecific incorporation of pAcF at single and multiple sites. Experimental (Exper) and theoretical (Theor) mass peaks for each sfGFP variant are shown. Major peaks (color) in each spectrum coincide with the theoretical peaks for each species (see also Supplementary Fig. 11 ). Smaller peaks immediately to the right of the major peaks are due to oxidation of the protein, a common electrochemical reaction occurring during electrospray ionization. Experimentally determined masses are ≤ 1 p.p.m. in comparison of theoretical mass calculations. Owing to the size of pAcF, misincorporation would result in peaks present at lower m/z values relative to the colored theoretical peak acetyltransferase (CAT), dihydrofolate reductase (DHFR), and modified murine granulocyte-macrophage colony-stimulating factor (mGM-CSF) in our engineered C321.ΔA.759 extracts as compared to BL21 Star (DE3) extracts ( Supplementary Fig. 7a ). Autoradiograms of proteins produced using C321.ΔA.759 extract show production of full-length sfGFP, CAT, DHFR, and mGM-CSF ( Supplementary Fig. 7b and 7c ). In addition, we observed disulfide bond formation in the model mGM-CSF under an oxidizing CFPS environment (-DTT), as has been previously shown ( Supplementary Fig. 7c) 39, 40 . In sum, the development of enhanced extract source strains by MAGE enabled a general and high-yielding CFPS platform.
Multi-site ncAA incorporation into proteins in CFPS. We next aimed to test site-specific ncAA incorporation into proteins using our high-yielding CFPS platform from C321.ΔA.759-derived extracts and compare these results to reactions using extracts from BL21 Star (DE3) (containing RF1) and a partially recoded RF1-deficient engineered strain MCJ.559 based on rEc.E13.ΔA.
To do so, we transformed each organism with pEVOL-pAcF plasmid that expresses both orthogonal pAcF synthetase (pAcFRS) and tRNA (o-tRNA opt ) 41 . Then, we quantitatively assessed the incorporation of pAcF into sfGFP variants with up to five in-frame amber codons. CFPS reactions were supplemented with additional OTS components based on our previous work 27 . Specifically, we added 10 µg/mL of linear DNA encoding optimized orthogonal tRNA in the form of a transzyme (o-tRNA opt ) for in situ synthesis of the tRNA. The orthogonal pAcFRS was overproduced, purified as previously described, and added at a level of 0.5 mg/mL. The ncAA, in this case pAcF, was supplied at a level of 2 mM in each CFPS reaction. Total protein yields were quantified by 14 C-leucine radioactive incorporation. Production of wild-type and modified sfGFP containing one UAG codon (sfGFP-UAG) was increased 77% and 92% in C321.ΔA.759 extracts as compared with BL21 Star (DE3), and 120% and 145% as compared with MCJ.559, respectively ( Fig. 3a and Supplementary Fig. 8a) . Moreover, we observed that sfGFP-UAG was expressed at 90% the level of wild-type sfGFP. Owing to the absence of RF1 competition, the major protein produced was fulllength sfGFP using extracts derived from C321.ΔA.759 and MCJ.559, whereas truncated sfGFP was visible in reactions catalyzed by BL21 Star (DE3) extract, presumably due to RF1 competition ( Fig. 3a and Supplementary Fig. 8a) 30, 42 . Similar results were obtained with a second model protein, CAT with an in-frame amber codon at position 112 (CAT-UAG) ( Fig. 3a and Supplementary Fig. 8b ). When expressing CAT-UAG using MCJ.559 extract, similar levels of truncated CAT relative to BL21 Star (DE3) were observed; however, this is most likely due to an upregulation of rescue mechanisms for ribosome stalling in the partially recoded strain 34 . Single pAcF incorporation into CAT-UAG using C321.ΔA.759 lysate demonstrated only full-length product. Therefore, our completely recoded, genomically engineered C321.ΔA.759 strain provides benefits for efficient ncAA incorporation without detectable levels of truncation product. We then evaluated the ability of our high-yielding CFPS platform to facilitate incorporation of up to five identical ncAAs into sfGFP. For ease of analysis, a fluorescence assay was used, which indicated increased production of sfGFP in extracts from C321.ΔA.759 (Fig. 3b) . Results for BL21 Star (DE3) extract displayed an exponential decrease in active sfGFP synthesized with an increasing presence of UAG, leading to the production of no detectable active protein for sfGFP-5UAG. Active protein produced by C321.ΔA.759 extract were~2-fold greater than that produced by MCJ.559 extract, suggesting that benefits observed in increased yield can be extended to multi-site ncAA incorporation for our enhanced, fully recoded strain. Furthermore, we examined the ability to incorporate consecutive pAcFs into single protein. Protein gel and autoradiogram analysis of sfGFP with eight and nine consecutive amber codons indicated that this is possible, with the percent of full-length product being~75% and 60%, respectively ( Supplementary Fig. 9 ).
In addition, batch reactions catalyzed by C321.ΔA.759 extracts could also be scaled 17-fold without loss of productivity provided that a proper ratio of surface area to volume ratio is maintained ( Supplementary Fig. 10) 43 . Of note, we believe our reactions could be further scaled to a wide range of volumes to produce larger amounts of protein if accounting for surface area to volume effects. For example, Sutro Biopharma has applied E. coli-based CFPS platforms to clinical manufacturing of therapeutics at the 100 L scale 44 , with an expansion factor of 10 6 . In terms of cost, although we use a phosphoenolpyruvate (PEP)-based CFPS system here, cellular metabolism could be used to fuel cost effective, high-level protein synthesis suitable for manufacturing applications 45, 46 .
After demonstrating benefits for protein expression, we carried out top-down mass spectrometry (i.e., MS analysis of whole intact proteins) to detect and provide semi-quantitative data for the incorporation efficiency of pAcF into sfGFP using extract derived from C321.ΔA.759. Figure 3c shows the 28 + charge state of sfGFP and clearly illustrates mass shifts corresponding to the incorporation of one, two, and five pAcF residues. Site-specific incorporation of pAcF, as detected by MS, was ≥ 98% in all samples, with ≤ 1 p.p.m. difference between experimental and theoretical protein masses ( Supplementary Fig. 11 ). In other words, efficient and high yielding site-specific pAcF incorporation into sfGFP was observed when using C321.ΔA.759 extract. We went on to further show that extracts generated from C321. ΔA.759 are compatible with multiple OTSs, showing the incorporation of p-propargyloxy-L-phenylalanine and p-azido-Lphenylalanine (pAzF) ( Supplementary Fig. 12 ).
Multi-site ncAA incorporation into ELPs. We next explored the synthesis of sequence-defined biopolymers containing tens of site specifically introduced ncAAs using our efficient and tunable CFPS system. As a model biopolymer, we selected ELPs. ELPs are biocompatible and stimuli-responsive biopolymers that can be applied for drug delivery and tissue engineering 47, 48 . Typically, ELPs consist of repeats of the pentapeptide sequence VPGVG, which is known to be a key component in elastin and exhibits interesting self-assembly behavior (random coil to helix) above its transition temperature. The structure and function of elastin is maintained as long as the glycine and proline residues are present; however, the second valine residue is permissive for any amino acid except proline and is therefore also permissive to ncAAs 20 . Previously, ncAAs have been introduced into ELPs by substituting natural amino acids with structurally similar ncAAs in CFPS systems 49 . Conticello and colleagues 50 have also previously produced imperfect ELPs containing up to 22 ncAAs in vivo using an E. coli strain with an attenuated activity of RF1. We previously incorporated up to 30 ncAAs into ELPs by evolving orthogonal synthetases in vivo with enhanced specificities 20 . In this study, we constructed and tested in CFPS three ELP constructs containing 20, 30, and 40 UAG codons, as well as control proteins with tyrosine codons substituted for UAGs.
Before characterizing ELP yields, we first carried out a series of optimization experiments to enhance CFPS yields of sfGFP with 5 UAG codons, as expression yields for this construct were reduced in our initial studies (Fig. 3b ). By testing total and soluble protein yields, we determined that the reduction in yield was a result of loss in sfGFP solubility and activity ( Supplementary Fig. 13 ).
However, a 31% increase in sfGFP-5UAG production was observed upon increasing pAcFRS levels 2-fold, pAcF levels 2.5fold, and o-tz-tRNA opt 3-fold ( Supplementary Fig. 14) . Upon application of these optimized conditions, called OTS opt , to the synthesis of ELP-UAGs containing 20, 30, and 40-mers, total yields increased by 40%, 33%, and 26%, respectively, as compared with supplementing with OTS levels optimized for 1 ncAA incorporation ( Supplementary Fig. 15 ). ELP-UAG products were visualized using an autoradiogram, which demonstrated the high percentage of full-length protein and whose band intensities corroborate total yields measured ( Supplementary Fig. 15b ).
We next applied OTS opt to the synthesis of ELP-UAGs with 20, 30, and 40-mers in the presence and absence of pAcF to demonstrate specificity of incorporation. ELP-UAGs were only synthesized in the presence of pAcF without any clear indication of truncation products, whereas no protein was observed in the absence of pAcF (Fig. 4 ). We anticipated that yields would decrease as the number of UAG codons increased due to the higher demand of pAcF-charged o-tRNA. In contrast, near wild type yields of~100 mg/L were obtained for all UAG constructs. We then carefully examined the efficiency of multi-site ncAA incorporation using top-down liquid chromatography (LC)-MS of intact ELPs. LC-MS analysis showed ≥ 98% site-specific pAcF incorporation in ELP-UAG constructs of 20, 30, and 40-mers ( Fig. 4) .
Discussion
We present a crude extract-based CFPS platform based on the fully recoded C321.ΔA strain that is capable of high-level protein expression. This platform was generated using MAGE to create libraries of improved extract chassis strains by targeting the functional inactivation of multiple negative effectors. A combinatorial disruption of the genes endA − , gor − , rne − , and mazF − (C321.ΔA.759) increased total CFPS yields from 397 ± 24 mg/L in the parent strain to 1,780 ± 30 mg/L of sfGFP, which is the highest reported protein yield from RF1-deficient extracts. These improvements translated to the enhanced yield of proteins harboring site specifically introduced ncAAs.
By optimizing the cell-free environment for multiple-identical ncAA incorporation, we were able to achieve multi-site ncAA incorporation into multiple model proteins with high yields (9 9% wild-type sfGFP expression yields for up to 2 ncAAs,~95% wild-type ELP expression yields for up to 20 ncAAs, and~85% WT  WT  kDa  kDa  198   98   62  49   38   28   17   198   98   62  49   38   28   17   L   WT  UAG  UAG  WT  UAG  UAG   20 30 40 20 30 40 20 30 40 20 30 40  20 30 40 20 30 40 20 30 40 20 30 wild-type ELP expression yields for up to 30 and 40 ncAAs) and purity ( ≥ 98% accuracy of ncAA incorporation) due to the absence of RF1 in our system. To our knowledge, these are the purest polymers with this many site-specifically introduced ncAAs (i.e., 40) synthesized to date. This exceeds our previous effort in cells that could synthesize ELP constructs with 30 UAG codons with 71% of the proteins having the desired 30 pAcF residues 20 . As such, our approach opens opportunities to sitespecifically modify the dominant physical and biophysical properties of biopolymers. This will allow researchers to go beyond tag-and-modify approaches that have historically been the focus of ncAA incorporation efforts, because the field was previously limited to only one or a few instances of site-specific incorporation. Notably, our protein expression yields of~1,700 mg/L and 99% suppression efficiency for sfGFP with 2 ncAAs outperform the best expression of proteins with single or multiple ncAAs in vivo, to our knowledge ( Fig. 2d and Supplementary Fig. 13 ).
For example, previous in vivo experiments using an RF1 knockout strain demonstrated the synthesis of enhanced GFP containing one, two, and three pAcFs at 3.5, 3.5, and 5.4 mg/L, respectively, corresponding to amber suppression efficiencies of 23%, 23%, and 36% 51 . Also in a separate report, an E. coli strain with attenuated RF1 activity produced 21, 17, and 27 mg/L of sfGFP with 3, ELP with 12, and ELP with 22 ncAAs incorporated, respectively 50 . However, increasing the number of amber codons (i.e., 12 and 22 ncAA incorporation) resulted in numerous truncation products. Here we demonstrate a cell-free system from engineered recoded bacteria that enables high yields of proteins containing up to 40 ncAAs with no observable truncation products. Thus, our cell-free system will serve as a complement to in vivo methods and be a useful technology for developing OTSs for robust synthesis of modified proteins. Looking forward, incorporating our discovered mutations into a recently published optimized strain, C321.ΔA.opt, might further increase the protein expression yields. 52 In addition, as new genomically recoded organisms with free codons are constructed 24, [53] [54] [55] [56] [57] , the development of extract chassis strains enabled by our MAGE-guided approach could aid the generation of highly efficient CFPS systems capable of incorporating two or more distinct ncAAs into a single protein or sequence-defined polymer. We envision that the generalized CFPS platform described here will be applied to on-demand biomanufacturing and biomolecular prototyping to transform biochemical engineering and expand the range of genetically encoded chemistry of biological systems.
Methods
Strains and plasmids. The bacterial strains and plasmids used in this study are listed in Supplementary Table 3 . Details for strain construction, plasmid construction, verification, and culture growth are provided in the Supplementary Methods.
Cell extract preparation. For prototyping engineered strains, cells were grown in 1 L of 2 × YTPG media (pH 7.2) in a 2.5 L Tunair shake flask and incubated at 34°C and 220 r.p.m. to OD 600 of 3.0. Cells were pelleted by centrifuging for 15 min at 5000 × g and 4°C, washed three times with cold S30 buffer (10 mM tris-acetate pH 8.2, 14 mM magnesium acetate, 60 mM potassium acetate, 2 mM dithiothreitol) 58 , and stored at − 80°C. To make cell extract, the thawed cells were suspended in 0.8 mL of S30 buffer per 1 g of wet cell mass and processed as reported by Kwon and Jewett 59 . Full details for cell growth, collection, and CFPS extract preparation are provided in the Supplementary Methods.
CFPS reactions. The PANOx-SP system was utilized for CFPS reactions 46 . Briefly, a 15 µL CFPS reaction in a 1.5 mL microcentrifuge tube was prepared by mixing the following components: 1.2 mM ATP; 0.85 mM each of GTP, UTP, and CTP; 34 µg/mL folinic acid; 170 µg/mL of E. coli tRNA mixture; 13.3 µg/mL plasmid; 16 µg/ mL T7 RNA polymerase; 2 mM for each of the 20 standard amino acids; 0.33 mM nicotinamide adenine dinucleotide; 0.27 mM coenzyme-A; 1.5 mM spermidine; 1 mM putrescine; 4 mM sodium oxalate; 130 mM potassium glutamate; 10 mM ammonium glutamate; 12 mM magnesium glutamate; 57 mM HEPES pH 7.2; 33 mM PEP); and 27% v/v of cell extract. For ncAA incorporation, 2 mM pAcF, 0.5 mg/mL pAcFRS, and 10 µg/mL of o-tz-tRNA opt linear DNA were supplemented to cell-free reactions. For multi-site and consecutive ncAA incorporation, OTS opt levels were increased to 5 mM pAcF, 1 mg/mL pAcFRS, and 30 µg/mL o-tz-tRNA opt . o-tRNA opt linear DNA was amplified from pY71-T7-tz-o-tRNA opt plasmid as described previously and transcribed during the cell-free reaction 27 . Furthermore, the o-tRNA opt was expressed in the source strain via a plasmid prior to extract preparation. Techniques for purifying aminoacyl tRNA synthetases are described in the Supplementary Methods. When testing the effect of RNAse inhibitor, 1 µL (4U) of inhibitor (Qiagen, Valencia, CA) was added into each 15 µL reaction as per the manufacturer's suggestion. Each CFPS reaction was incubated for 20 h at 30°C unless noted otherwise. Fed-batch and scale-up reaction formats are described in the Supplementary Methods.
Protein quantification. Protein quantification was performed using fluorescence detection and radioactive 14 C-Leucine incorporation and scintillation counting as described in the Supplementary Methods.
Whole-genome sequencing. As the gene encoding MutS is inactivated in C321. ΔA, we chose to fully sequence the genomes of six key strains produced during our screening efforts (C321.ΔA, C321.ΔA.542, C321.ΔA.705, C321.ΔA.709, C321. ΔA.740, and C321.ΔA.759). Whole-genome sequencing was performed by the Yale Center for Genome Analysis for library prep and analysis as described previously 60 (see Supplementary Methods). Genomes have been deposited to NCBI SRA collection, accession number PRJNA361365 (Individual accession numbers: SRX2511757-SRX2511762).
Nucleotide and amino acid quantitation using HPLC. Amino acid and nucleotide concentrations were measured via high-performance LC (HPLC). Cell-free reactions were clarified by precipitation with an equal volume 5% w/v trichloroacetic acid. Samples were centrifuged at 12,000 × g for 15 min at 4°C and the supernatant stored at − 80°C until analyzed using an Agilent 1290 series HPLC system (Agilent, Santa Clara, CA). For amino acid analysis, a Poroshell HPH-C18 column (4.6 × 100 mm, 2.7 µm particle size; Agilent) was used with an automatic precolumn derivatization method using o-pthalaldehyde and fluorenylmethyl chloroformate 61 . Nucleotides were analyzed using a BioBasic AX column (4.6 × 150 mm, 5 µm particle size; Thermo Scientific, West Palm Beach, FL). Full methods are described in the Supplementary Methods.
Full-length sfGFP and ELP purification and MS analysis. To confirm pAcF incorporation at corresponding amber sites, LC-MS analysis was performed on purified sfGFP and ELP reporter protein constructs with pAcF putatively incorporated. MS procedures and sample preparation details are given in the Supplementary Methods.
